Canada markets closed

ATRA Sep 2024 0.500 call

OPR - OPR Delayed Price. Currency in USD
Add to watchlist
0.20000.0000 (0.00%)
At close: 10:38AM EDT
Full screen
Loading interactive chart...
  • Business Wire

    Atara Biotherapeutics’ Ebvallo™ (tabelecleucel) Wins Prix Galien International Award for Best Product for Orphan/Rare Diseases

    THOUSAND OAKS, Calif., June 21, 2024--Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, today announced that EbvalloTM (tabelecleucel or tab-cel®) has been awarded the prestigious 2024 Prix Galien International Award for "Best Product for Orphan/Rare Diseases." The award was presented to Pierre Fabre Laboratorie

  • Business Wire

    Atara Biotherapeutics Announces 1-for-25 Reverse Stock Split

    THOUSAND OAKS, Calif., June 17, 2024--Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, today announced that it will conduct a reverse stock split of its outstanding shares of common stock at a ratio of 1-for-25 (the "Reverse Stock Split"). The Reverse Stock Split will become effective at 12:01 a.m. Eastern Time

  • GlobeNewswire

    Presenting on the Emerging Growth Conference 72 Day 2 on June 13 Register Now

    MIAMI, June 12, 2024 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 72nd Emerging Growth Conference on June 12 & 13, 2024. The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long-term growth. Register for the Conference here. Submit Questions for any of the presenting compani